Return to search results
Prasugrel
Prasugrel is a prescription medication that prevents blood clots by inhibiting platelet aggregation, reducing the risk of heart attack or stroke in patients with acute coronary syndromes. Available as 5mg and 10mg oral tablets, it's a generic version manufactured by Apotex Corp. under ANDA205897. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Prasugrel is a prescription medication that prevents blood clots by inhibiting platelet aggregation, reducing the risk of heart attack or stroke in patients with acute coronary syndromes. Available as 5mg and 10mg oral tablets, it's a generic version manufactured by Apotex Corp. under ANDA205897. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Prasugrel",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Prasugrel — ANDA 205927 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205927"
}
]
|
| identifier | ANDA205927 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"drug-safety",
"fda",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Prasugrel |
